Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease
about
Physiological and Pharmacological Roles of FGF21 in Cardiovascular DiseasesImplication of hepatokines in metabolic disorders and cardiovascular diseasesRoles of FGFs As Paracrine or Endocrine Signals in Liver Development, Health, and DiseaseThe FGF21-adiponectin axis in controlling energy and vascular homeostasisFibroblast Growth Factor 21 Analogs for Treating Metabolic Disorders.Roles of FGF Signals in Heart Development, Health, and DiseaseFibroblast growth factors in cardiovascular disease: The emerging role of FGF21Irisin levels are lower in young amenorrheic athletes compared with eumenorrheic athletes and non-athletes and are associated with bone density and strength estimatesHepatokines as a Link between Obesity and Cardiovascular Diseases.Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patientsSerum Level of Fibroblast Growth Factor 21 Is Independently Associated with Acute Myocardial Infarction.Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes.Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes.Fibroblast growth factor 21 deletion aggravates diabetes-induced pathogenic changes in the aorta in type 1 diabetic mice.Minireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic Regulation and Chronic DiseasesFibroblast growth factor-21 is positively associated with atrial fibrosis in atrial fibrillation patients with rheumatic heart disease.Circulating Fibroblast Growth Factor 21 is Associated with Diastolic Dysfunction in Heart Failure Patients with Preserved Ejection Fraction.Diagnostic Value of CK-18, FGF-21, and Related Biomarker Panel in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.Contribution of serum FGF21 level to the identification of left ventricular systolic dysfunction and cardiac death.Fibroblast growth factor 21: a regulator of metabolic disease and health span.Cardiac actions of fibroblast growth factor 23.Epicardial fat, body mass index, and triglyceride are independent contributors of serum fibroblast growth factor 21 level in obese premenopausal women.Fibroblast growth factor 21 protects rat cardiomyocytes from endoplasmic reticulum stress by promoting the fibroblast growth factor receptor 1-extracellular signal‑regulated kinase 1/2 signaling pathway.Fibroblast growth factor 21 potentially inhibits microRNA-33 expression to affect macrophage actionsThe alterations of serum FGF-21 levels, metabolic and body composition in early breast cancer patients receiving adjuvant endocrine therapy.Muscle mitochondrial stress adaptation operates independently of endogenous FGF21 action.Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus.Low Plasma Levels of Fibroblast Growth Factor-21 in Patients with Peripheral Artery Disease.The relationship of circulating fibroblast growth factor 21 levels with incident atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis.Serum Fibroblast Growth Factor 21 and New-Onset Metabolic Syndrome: KoGES-ARIRANG Study.Impact of fibroblast growth factor 21 on the secretome of human perivascular preadipocytes and adipocytes: a targeted proteomics approach.The role of FGF21 in type 1 diabetes and its complications.A high circulating FGF21 level as a prognostic marker in patients with acute myocardial infarctionCirculating level of fibroblast growth factor 21 is independently associated with the risks of unstable angina pectoris
P2860
Q26744232-ED9F6F72-E062-47DF-AECD-DB47C1C64EBFQ26751147-742E8DBD-0C87-4C4D-B28F-D381A1F1EE54Q26752330-38A82CF6-B8B6-4B22-B674-707809A5F7B2Q26753369-BDDE5FEA-1985-4918-916D-AF37E271BF7CQ27686803-DCC219AA-D0AB-4EF0-A264-0FCAB8E2321AQ28072691-ABB11DC3-3BE1-4504-AEEF-CDADFE18EB76Q28084197-4A09B851-96DA-4E07-810C-62373A7C0309Q33754566-DE162EDA-2AAB-4E1C-BE41-0D3144369CE5Q35126823-B3C0F3A3-D073-4FFE-B885-7CEA44FC4E74Q35176887-36279F63-E288-4459-BA06-3064CFA4B145Q35668795-1684B5A5-25ED-4D9C-B5DF-7D0A74EA7AC8Q35762326-7F1C08D2-18BA-4CDD-A143-C3826F8CD95CQ35784028-6E05F3E4-BB15-4821-8E46-EE0448E011C3Q35794417-7AAB431B-782A-4C11-A4CA-99FAC653EA69Q36107291-38334633-BA50-4841-9BEC-FE985B723A8DQ36464699-E3BD07C2-7964-48E5-8F05-5E9BE8D23FFAQ37271698-FFE966EE-07AA-4C92-AF18-B90041214C81Q37689828-EADD7F28-B1A4-4303-B8BC-5180BF9CA3DCQ38618204-4324A1F5-C65B-47E1-A38F-4E576B871F04Q38755577-EC9483D7-A54F-4381-8B51-DBDECC9E107CQ38977291-36E22E1A-CBBB-49D2-A576-C627622F432DQ39113702-6A44C351-054D-4968-ACCC-85665057A87EQ41834382-AA197FFF-280E-4789-B8FA-5DFEDD06E3DBQ42359780-66189BDC-F3BA-414A-81D5-9CF3F7DAC57AQ42504526-B989B0E9-7422-41DC-B981-AD0F4B91FE6AQ42541271-DDCA1E89-4E08-4B41-8827-CBC84BCED6A0Q47135571-BC1F4996-E4E8-43E7-A8E6-3A00AA261016Q47547083-BDDB103C-51AC-46AE-8D65-F9E4BE9906AFQ49914044-7A208150-563F-4E0D-BE24-5B64C57A62BCQ50049416-3337D613-651C-440A-8CB7-27239C89374FQ51592405-76FD4FF6-2CEF-437D-92F9-6068AFD4CDE3Q55513236-2EE4AAA2-B1A4-4D43-864E-341CA0BBB7E6Q57493364-48C2678D-941D-45BF-83EB-59C366682317Q58699532-ED74F0AA-060F-48FC-B581-3560747A14B0
P2860
Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Additive relationship between ...... el and coronary artery disease
@en
Additive relationship between ...... l and coronary artery disease.
@nl
type
label
Additive relationship between ...... el and coronary artery disease
@en
Additive relationship between ...... l and coronary artery disease.
@nl
prefLabel
Additive relationship between ...... el and coronary artery disease
@en
Additive relationship between ...... l and coronary artery disease.
@nl
P2093
P2860
P356
P1476
Additive relationship between ...... el and coronary artery disease
@en
P2093
Meifang Gao
Weiping Jia
Xiaojing Ma
Xiaoping Pan
Yaping Hao
Yuqian Bao
Zhigang Lu
P2860
P2888
P356
10.1186/1475-2840-12-124
P407
P577
2013-08-28T00:00:00Z
P5875
P6179
1037766877